The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
The Unit has been issued GMP Certification from ANVISA-Brazil
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
_256_384.png)
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
A five-day inspection was concluded successfully with no critical and no major observations raised
The company is confident of addressing the concern raised by the USFDA
Subscribe To Our Newsletter & Stay Updated
